RBC Capital keeps a Buy rating and $82 price target on Cytokinetics (CYTK), saying the firm remains bullish on the stock following the ...
2d
Fintel on MSNRBC Capital Initiates Coverage of Vertiv Holdings (VRT) with Outperform RecommendationFintel reports that on March 7, 2025, RBC Capital initiated coverage of Vertiv Holdings (NYSE:VRT) with a Outperform ...
In a report released today, Manjari Dhar from RBC Capital maintained a Buy rating on Zalando (0QXN – Research Report), with a price target of ...
Barclays has hired John Kolz from RBC Capital Markets to be global co-head of equity capital markets in New York. Barclays ...
Fintel reports that on March 7, 2025, RBC Capital initiated coverage of GH Research (NasdaqGM:GHRS) with a Outperform ...
Investing.com -- Galderma Group AG has been downgraded by RBC Capital Markets to "sector perform" from "outperform," ...
RBC Capital raised the firm’s price target on AdaptHealth (AHCO) to $14 from $11 and keeps an Outperform rating on the shares ...
RBC Capital Markets Global Financial Institutions Conference Transcript March 5, 2025 11:20 AM ETCompany ParticipantsJohn Stern ...
Chinese authorities are rolling out fresh measures to limit capital flight, including increased scrutiny of overseas ...
In the second quarter of last year, RBC closed its deal to takeover HSBC Bank Canada, which was Canada’s seventh-largest ...
Toronto-Dominion Bank beat estimates on better-than-expected wealth-management and capital-markets results, capping off an ...
Three of Canada's big five lenders - Royal Bank of Canada, TD Bank and CIBC - on Thursday beat analyst expectations for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results